Presentation TCT 2016 Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR! Presenter: Isaac George October 30, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Aortic Valve Up Next Presentation TCT 2016 Evolution of the Nurse/Tech Role in the Cath Lab Presenter: Mary K. Egan October 30, 2016 More slides + Presentation TCT 2016 Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff October 30, 2016 Presentation TCT 2016 Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion? Presenter: Gregg W. Stone October 30, 2016 We Recommend
Presentation TCT 2016 Evolution of the Nurse/Tech Role in the Cath Lab Presenter: Mary K. Egan October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff October 30, 2016
Presentation TCT 2016 Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion? Presenter: Gregg W. Stone October 30, 2016